ALT5 Sigma cancels Alyea spin-off as previously planned; evaluating other strategic options

AI Financial Corp

The spin-off of Alyea Therapeutics will not occur with the June 2, 2025 record date as previously disclosed.
The transaction may not proceed under the original timeline; future spin-off or similar transaction remains possible.
Company remains encouraged by Alyea's non-addictive pain treatment patents and potential clinical trial progression.
ALT5 continues to evaluate strategic alternatives to maximize and realize value from Alyea.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.